Intuitive Surgical filings document operating results, governance matters, capital structure, and material events for a Nasdaq-listed medical technology company focused on robotic-assisted surgery. Its Form 8-K reports furnish quarterly and preliminary financial results, procedure information, and exhibits tied to da Vinci and Ion business performance.
Regulatory filings also cover shareholder voting matters, proxy governance, executive compensation, director elections, and officer-role changes. Other material-event disclosures record completed corporate actions, including the acquisition of da Vinci and Ion distribution operations in Europe, alongside formal disclosures about common stock and financial reporting matters.
Myriam Curet McAdams notified a proposed sale of 2,345 common shares under a Form 144 filing. The filing lists the securities as restricted stock to be sold through Morgan Stanley Smith Barney LLC on 02/26/2026.
The filing also discloses multiple recent open-market dispositions by the same holder: 421 shares on 02/11/2026, 105 shares on 02/10/2026, 126 shares on 01/29/2026, 230 shares on 01/27/2026, 104 shares on 12/10/2025, and 125 shares on 12/01/2025, each with the reported transaction proceeds in dollars.
Intuitive Surgical SVP Iman Jeddi reported multiple equity compensation transactions dated February 26, 2026. He was granted 2,793 performance stock units originally awarded on February 28, 2023, after the Compensation Committee confirmed performance goals were achieved; these PSUs vest on February 28, 2026, subject to continued service. He also received a new grant of 4,480 restricted stock units that vest 25% annually over four years. Previously granted RSUs converted into 1,622 and 687 shares of common stock on a one-for-one basis as they vested, with 631 and 341 shares of common stock withheld at a price of $506.17 per share to cover statutory tax obligations. Following these transactions, he holds direct common stock and derivative awards, and 26,649 additional common shares are held indirectly by a trust.
Intuitive Surgical executive Henry L. Charlton reported multiple equity awards and share settlements related to prior grants. On February 26, 2026, he received 3,591 performance stock units granted in 2023 and 4,032 new restricted stock units, all at a stated price of $0.00 per unit.
On the same date, 1,717 and 1,030 restricted stock units converted into common stock, while 765 and 459 common shares were withheld to cover tax obligations tied to these vestings. Following these transactions, he directly held 5,220 shares of Intuitive Surgical common stock.
Intuitive Surgical EVP & CFO Jamie Samath reported multiple equity-compensation transactions in company stock. He received a grant of 3,591 performance stock units originally awarded on February 28, 2023, after performance criteria were certified, and 6,720 new restricted stock units granted on February 26, 2026. In addition, 1,908 and 1,488 restricted stock units from prior awards converted into common shares at no cash cost, reflecting scheduled vesting. To cover statutory tax withholding on these vestings, 900 and 738 common shares were withheld and delivered for taxes, leaving the remaining net shares in his account.
Intuitive Surgical executive Gary Loeb, EVP & Chief Legal and Compliance, reported several equity-related transactions in company stock. On February 26, 2026, he acquired shares of common stock through the vesting and conversion of previously granted restricted stock units and performance stock units, and also received new equity awards.
The filing shows tax-withholding dispositions of 757 and 455 shares of common stock at $506.17 per share to cover statutory obligations, rather than open-market sales. Loeb was also granted 1,050 performance stock units tied to previously achieved performance metrics and 3,584 new restricted stock units that vest 25% annually over four years.
Intuitive Surgical executive Myriam Curet, EVP & Chief Medical Officer, reported several equity-related transactions in company stock and units. She received a grant of 2,793 performance stock units tied to performance goals that vest on February 28, 2026, three years after the original grant date.
Previously granted restricted stock units were converted into common shares as they vested, including 3,052 and 1,602 RSUs that settled at no cash exercise price. Related common shares are held indirectly by a trust. To satisfy statutory tax withholding, the trust delivered 1,514 and 795 shares at a price of $506.17 per share, with remaining net shares deposited into the holder’s account.
Intuitive Surgical VP Corporate Controller Fredrik Widman reported multiple equity transactions on February 26, 2026. He acquired 611 and 378 shares of common stock through the vesting and conversion of previously granted restricted stock units (RSUs), and received a new award of 1,627 RSUs that will vest in 25% annual installments over four years.
To cover statutory tax withholding on the RSU vesting, 303 and 188 shares of common stock were withheld at a price of $506.17 per share, rather than being sold in the open market. After these transactions, his directly held common stock and RSU balances increased, reflecting routine compensation-related activity.
INTUITIVE SURGICAL INC director and CEO David J. Rosa reported multiple equity compensation transactions dated February 26, 2026. He acquired 4,788 performance stock units originally granted on February 28, 2023 and 3,018 performance stock units originally granted on June 12, 2023, after performance criteria were certified as achieved. These performance units are scheduled to vest on February 28, 2026, subject to continued service.
Rosa also received a new grant of 13,441 restricted stock units dated February 26, 2026, which vest 25% per year over four years. In addition, 3,816 and 2,289 previously granted restricted stock units were exercised into common stock on a one-for-one basis, with 1,892 and 1,135 common shares respectively withheld at a price of 506.17 per share to cover statutory tax obligations. After these transactions, he directly owned 232,648 shares of common stock.
Intuitive Surgical director Gary S. Guthart reported multiple equity award transactions. He received 8,778 performance stock units granted on February 28, 2023 after performance criteria were achieved, which are scheduled to vest on February 28, 2026, subject to continued service.
He also acquired 4,960 and 3,433 shares of common stock through the vesting and conversion of restricted stock units, with related dispositions of 2,460 and 1,703 shares at $506.17 per share to cover statutory tax withholding obligations. Following these transactions, he holds 9,251 shares of common stock directly, plus additional indirect holdings through family trusts.